Dong Luo Associate Professor (PI)
E-mail：luodong09@scut.edu.cn
2022-present South China University of Technology, Associate Professor
2017-2022 Case Western Reserve University, Postdoctoral researcher
2013-2017 Queen Mary University of London, Ph.D
2009-2013 Sichuan University, B.Sc
Molecular imaging, Nanomedicine, Biomaterials
Prof. Luo’s research is focused on developing multifunctional molecular imaging probes for the diagnosis and therapy of diseases. As a primary investigator, he has finished the Cleveland VeloSano fund, and has applied and finished two NIH RO1 projects as a key investigator. Prof. Luo's work has been published in top academical journals, such as JACS, ACS Nano, Nano Letters, Chemical Science, Small, ACS Applied Materials & Interfaces, Biomacromolecules. He also authored two US patents, one of which has been licensed to Schottlander. Prof. Luo has been invited to speak at the annual meetings of the World Molecular Imaging Society (WMIS), Controlled Release Society (CRS),and Materials Research Society (MRS). He was awarded Andrew Carnegie Research Award by the Institute of Materials, Minerals and Mining (IOM3), Postgraduate Research Award and SEMS PhD Travel Award by Queen Mary University of London.
Luo D, Wang XN, Walker E, Springer S, Ramanurthy G, Burda C, Basilion JP.Targeted chemoradiotherapy of prostate cancer using gold nanoclusters with protease activatable Monomethyl Auristatin E. ACS Applied Materials & Interfaces 2022, 14(13), 14916–14927.
Li H,#Luo D,#Yuan C, Wang XN, Wang J, Basilion JP, Meade TJ. Magnetic resonance imaging of PSMA-positive prostate cancer by a targeted and activatable Gd(III) MR contrast agent. JACS2021, 143(41), 17097–17108.
Luo D, Wang XN, Walker E, Wang J, Springer S, Lou J, Ramanurthy G, BurdaC, Basilion JP. Nanoparticles yield increased drug uptake and therapeutic efficacy upon sequential near-infrared irradiation. ACS Nano2020, 14(11), 15193-15203.
Luo D, Johnson A, Wang XN, Springer S, Lou J,Ramanurthy G, Burda C, Meade TJ, Basilion JP. Targeted gold nanoparticles for MR-guided radiation therapy of prostate cancer. Nano Letters 2020, 20(10),7159-7167.
Luo D, Wang XN, Zeng S, Ramanurthy G, Burda C, Basilion JP. Targeted gold nanocluster-enhanced radiotherapy of prostate cancer. Small 2019,15(34), 1900968.
Luo D, Wang XN, Zeng S, Ramanurthy G, Burda C, Basilion JP.Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles? ChemicalScience 2019, 10(35), 8119-8128.
Luo D, Poston RN, Gould DJ, SukhorukovGB. Magnetically targetable microcapsules display subtle changes in permeabilityand drug release in response to a biologically compatible low frequency alternating magnetic field. Materials Science and Engineering: C 2019, 94, 647-655.
Luo D, Shahid S, Hasan MS, Whiley R,Sukhorukov GB, Cattell MJ. Controlled release of chlorhexidine from a HEMA-UDMAresin using a magnetic field. Dental Materials 2018, 34 (5), 764–775.
Luo D, Zhang X, Shahid S, Cattell MJ,Gould DJ, Sukhorukov GB. Electrospun poly(lactic acid) fibers containing novelchlorhexidine particles with sustained antibacterial activity. Biomaterials Science 2017, 5(1),111-119.
Luo D, Shahid S, Sukhorukov GB, CattellMJ. Synthesis of novel chlorhexidine spheres with controlled release from aUDMA–HEMA resin using ultrasound. Dental Materials 2017, 33 (6), 713–722.
Luo D, Hasan MS, Shahid S, Khlebtsov BN,Cattell MJ, Sukhorukov GB. Gold nanorod mediated chlorhexidine microparticle formation and near-infrared light induced release. Langmuir 2017, 33 (32), 7982–7993.
Luo D, Shahid S, Wilson RM, Cattell MJ, Sukhorukov GB. Novel formulation of chlorhexidine spheres and sustained release with multilayered encapsulation. ACS Applied Materials & Interfaces2016, 8(20), 12652-12660.
Luo D, Gould DJ, Sukhorukov GB. Local and sustained activity of doxycycline delivered with layer-by-layer microcapsules. Biomacromolecules 2016, 17(4), 1466-1476.